Ventrella Domenico, Ashkenazi Nurit, Elmi Alberto, Allegaert Karel, Aniballi Camilla, DeLise Anthony, Devine Patrick John, Smits Anne, Steiner Lilach, Forni Monica, Bouisset-Leonard Michele, Bacci Maria Laura
Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emlia, 40064 Bologna, Italy.
Global Research and Development, Teva Pharmaceutical Industries Ltd., Netanya 42504, Israel.
Animals (Basel). 2021 Mar 5;11(3):714. doi: 10.3390/ani11030714.
The present review aims to summarize the main features of mammary gland anatomy, and the physiology of lactation and colostrum/milk in the most commonly used animal species for regulatory toxicity. The final goal is the selection of a preferred animal species to be enrolled in studies investigating the potential transfer of drugs and exogenous molecules through milk, within the Innovative Medicines Initiative (IMI) funded project ConcePTION. Reference data regarding humans were also collected and analyzed in order to highlight critical similarities and differences with the studied species. Additional practical considerations were also taken into account, such as ethical consideration regarding the chosen species which affects the group size, financial implications and technical feasibility of lactation trials (e.g., ease of sampling, volume of sampling, husbandry requirements and scientific recognition). In conclusion, the present analysis of the literature confirms the complexity of the decisional process behind the choice of an animal model for in vivo trials. For some of the evaluated species, data were either poor or missing, highlighting the necessity to generate more physiological background studies for species that are routinely used in laboratory settings. Overall, when taking into consideration ethical factors, feasible group size, milk volume and ease of milk collection, and physiological similarities with humans, minipigs seem to represent the most appropriate choice.
本综述旨在总结用于监管毒性研究的最常用动物物种的乳腺解剖结构、泌乳生理以及初乳/乳汁的主要特征。最终目标是在创新药物计划(IMI)资助的ConcePTION项目中,选择一种首选动物物种用于研究药物和外源性分子通过乳汁的潜在转移情况。还收集并分析了关于人类的参考数据,以突出与所研究物种的关键异同点。此外,还考虑了其他实际因素,例如所选物种的伦理考量(这会影响组群大小)、泌乳试验的财务影响和技术可行性(例如采样的难易程度、采样量、饲养要求和科学认可度)。总之,目前对文献的分析证实了体内试验动物模型选择背后决策过程的复杂性。对于一些评估物种,数据要么匮乏要么缺失,这凸显了有必要针对实验室常规使用的物种开展更多生理背景研究。总体而言,在考虑伦理因素、可行的组群大小、乳汁量和乳汁采集的难易程度以及与人类的生理相似性时,小型猪似乎是最合适的选择。